Blog
RSS FeedPosted by Michael Wonder on 20 Jan 2021
Scottish Health Technologies Group: enhancing patient engagement
20 January 2021 - The Scottish Health Technologies Group provides evidence support and advice to the National Health Service in Scotland ...
Posted by Michael Wonder on 04 Dec 2020
Access Consortium statement on COVID-19 vaccines evidence
4 December 2020 - The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the ...
Posted by Michael Wonder on 27 Oct 2020
Information specialist collaboration in Europe: collaborative methods, processes, and infrastructure through EUnetHTA
21 October 2020 - The history of European health technology assessment goes back more than 30 years. Almost as old as ...
Posted by Michael Wonder on 18 Oct 2020
Community engagement in health technology assessment and beyond: from guests in the process to hosts
15 October 2020 - In health technology assessment, clinical and economic evidence are assessed in the regulatory and reimbursement environments, with ...
Posted by Michael Wonder on 10 Oct 2020
In landmark international program, HTA agencies around the world access ICER's customisable COVID-19 cost-effectiveness model
9 October 2020 - Leveraging ICER’s new cloud-based Interactive Modeler platform, Quebec’s HTA agency has used the COVID-19 model to inform ...
Posted by Michael Wonder on 09 Oct 2020
MHRA to join Project Orbis
8 October 2020 - The UK is set to join the US FDA's Project Orbis at the start of next ...
Posted by Michael Wonder on 05 Oct 2020
Physician–patient shared decision making, patient satisfaction, and adoption of new health technology in China
2 October 2020 - A cross-sectional study was conducted from July 2016 to October 2016 in Fujian Province and Shanghai, in ...
Posted by Michael Wonder on 29 Sep 2020
Australian patients to benefit from ongoing collaboration between peak medicine bodies
29 September 2020 - ACCC extends conditional authorisation to Medicines Australia and the Generic and Biosimilar Medicines Association ...
Posted by Michael Wonder on 03 Sep 2020
CMS care compare empowers patients when making important health care decisions
3 September 2020 - Today, under the leadership of President Trump, the Centers for Medicare & Medicaid Services launched Care Compare, ...
Posted by Michael Wonder on 18 Aug 2020
Coronavirus updates: WHO calls for global co-operation and an end to 'vaccine nationalism'
19 August 2020 - The World Health Organization's chief says governments and drug-makers are putting their own interests ahead of ...
Posted by Michael Wonder on 19 Jul 2020
Drug regulators remain united on COVID-19, says EU agency boss
18 July 2020 - The fight among governments to secure treatments has brought regulators closer together, says Guido Rasi. ...
Posted by Michael Wonder on 13 Jul 2020
EUnetHTA is extended for one year and focuses on COVID-19
9 July 2020 - The European project EUnetHTA, in which TLV, SBU and the Swedish Medicines Agency are Swedish partners, ...
Posted by Michael Wonder on 09 Jul 2020
NICE signs agreement with Colombia’s Institute of Health Technology Assessment to forge closer working ties
9 July 2020 - Research and knowledge sharing key to collaborative working approach agreed the two agencies. ...
Posted by Michael Wonder on 07 Jul 2020
ISPOR Working Group provides a first-ever cross-stakeholder consensus definition of “Patient Engagement in Research”
7 July 2020 - Value in Health announced today the publication of results of an ISPOR systematic review and analysis ...
Posted by Michael Wonder on 06 Jul 2020
Launch of public consultation on joint network strategy to 2025
6 July 2020 - EMA and the Heads of Medicines Agencies have developed a joint strategy for the next five ...